DeepRescore

DeepRescore enhances peptide-spectrum match (PSM) rescoring in immunopeptidomics by integrating deep learning-derived retention time and MS/MS spectral features to improve identification of MHC-binding peptides and neoantigens from mass spectrometry (MS) data.


Key Features:

  • Deep learning integration: Utilizes deep learning predictions of retention time and MS/MS spectra to derive features that are combined with traditional features for rescoring PSMs.
  • Support for multiple search engines: Accepts initial identification results from MS-GF+, Comet, X!Tandem, and MaxQuant.
  • Input formats: Processes MS/MS data in Mascot Generic Format (MGF) alongside search-engine identification outputs.
  • Improved sensitivity and reliability: Incorporation of deep learning-derived features increases sensitivity and reliability of MHC-binding peptide and neoantigen identification compared to existing methods.

Scientific Applications:

  • Immunopeptidomics: Enhances identification of MHC-binding peptides from MS-based immunopeptidomics datasets.
  • Neoantigen discovery: Improves detection of candidate neoantigens for cancer immunotherapy studies.
  • Antigen presentation and immune-response analysis: Supports studies of antigen presentation relevant to vaccine development and immune-response characterization.

Methodology:

Inputs comprise MS/MS data in Mascot Generic Format (MGF) and initial identification results from supported search engines; a rescoring algorithm combines traditional PSM features with deep learning-derived retention time and MS/MS spectral predictions, and performance was validated on two public immunopeptidomics datasets.

Topics

Details

Tool Type:
command-line tool
Programming Languages:
R
Added:
1/18/2021
Last Updated:
2/27/2021

Operations

Publications

Li K, Jain A, Malovannaya A, Wen B, Zhang B. DeepRescore: Leveraging Deep Learning to Improve Peptide Identification in Immunopeptidomics. PROTEOMICS. 2020;20(21-22). doi:10.1002/pmic.201900334. PMID:32864883. PMCID:PMC7718998.

PMID: 32864883
PMCID: PMC7718998
Funding: - National Cancer Institute: U24 CA210954 - Cancer Prevention and Research Institute of Texas: RR160027